Old Web
English
Sign In
Acemap
>
authorDetail
>
Jean-Claude Tardif
Jean-Claude Tardif
Medicine
Internal medicine
Peroxisome proliferator-activated receptor
Agonist
Aleglitazar
2
Papers
123
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the dual peroxisome proliferator–activated receptor ?/? agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: Rationale and design of the AleCardio trial
2013
American Heart Journal
A. Michael Lincoff
Jean-Claude Tardif
B Neal
Stephen J. Nicholls
Lars Rydén
Gregory G. Schwartz
Klas Malmberg
John B. Buse
Robert R. Henry
Hans Wedel
Arlette Weichert
Ruth Cannata
Diederick E. Grobbee
Show All
Source
Cite
Save
Citations (0)
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
2006
Steven E. Nissen
Stephen J. Nicholls
Ilke Sipahi
Peter Libby
Joel S. Raichlen
Christie M. Ballantyne
Jean Davignon
Raimund Erbel
Jean-Claude Tardif
Paul Schoenhagen
Tim Crowe
Show All
Source
Cite
Save
Citations (123)
1